Julie Workman

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

M. Janusz Mezynski, Angela M. Farrelly, Mattia Cremona et al. · Journal of Translational Medicine · 2021 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer

Cha Len Lee, Mattia Cremona, Angela M. Farrelly et al. · Cancer Biology & Therapy · 2023 · 25 citations · Full text

Medicine, Oncology, Pharmacology +14

Mixed Approaches to CS0

Zoë J. Wood, John Clements, Zachary Peterson et al. · 2018 · 23 citations

Education, Computer Science, Instruction +14

Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel

Daniel J Ryan, Sinéad Toomey, Robert Smyth et al. · Lung Cancer · 2022 · 19 citations

Medicine, Molecular Biology, Oncology +14

Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models

Razia Aslam, Cathy E. Richards, Joanna Fay et al. · International Journal of Molecular Sciences · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17